This presentation reviewed current radiotherapy facilities in the United States and treatment modalities, including niche modalities. The expanding variety of modalities were discussed, and the rationale behind these proposals. The clinical aspects of new modalities, purchasing considerations, and emotional and strategic issues were also reviewed. Panelists defined an economic decision formula for new technology, and discussed how this impacts the stakeholders in radiotherapy.
Panelists included: Anthony M. Berson, M.D., Radiation Oncology, St. Vincent’s Comprehensive Cancer Center and Richard Emery, Vice President, Aptium Oncology, Inc.; Executive Director, Trinitas Comprehensive Cancer Center.
Related Insights
18 February 2025
DEA Delays Final Buprenorphine Rule
The Department of Health and Human Services and the Drug Enforcement Administration have delayed the effective date of the final rule regarding telemedicine prescribing of buprenorphine to March 21, 2025, and have requested public comments on the rule.
17 February 2025
Foley Viewpoints
6 Steps to Manage Tariff Risks in a Trade War
As Trump seeks to raise U.S. tariffs (which currently tend to be among the lowest worldwide), manufacturers, distributors, retailers, and other companies that frequently import must determine the best strategy to deal with the resulting uncertainties.
25 February 2025
Events
Navigating Tariffs and Supply Chain Contracts: Mitigating Financial and Legal Risks
Join Foley and Lardner LLP partners Greg Husisian, Leah Imbrogno, and Vanessa Miller on Tuesday, February 25, for a Strafford CLE webinar, “Navigating Tariffs and Supply Chain Contracts: Mitigating Financial and Legal Risks.”